EKR Therapeutics' Series D Round

EKR Therapeutics raised a round of funding on March 17, 2008.

EKR Therapeutics is a specialty pharmaceutical company committed to serving the acute-care hospital setting by identifying, commercializing, and marketing products to address unmet or undersatisfied m…

Articles about EKR Therapeutics' Series D Round: